AIDS Vaccines
Recombinant Multi-Antigen TBC-3B Vaccine Trial Commences
Published in Vaccine Weekly, July 7th, 1997
TBC-3B is a recombinant vaccine for the prevention of AIDS. The trial is the first study to evaluate TBC-3B in vaccinia-naive individuals, the potential target population, and to combine the vaccine with boosts of gp120, an HIV specific envelope glycoprotein developed by VaxGen, Inc., formerly part of Genentech, Inc. The clinical trial is being conducted at NIAID's six AIDS Vaccine Evaluation Units across the country.
"Therion's TBC-3B represents a unique...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1997-07-07)
More Articles from Vaccine Weekly
- Conference Coverage (SPIRAT/NCDDG-HIV)
Promising Early Results from CD4 Reconstitution Trial - Conference Coverage (SPIRAT/NCDDG-HIV)
Combined Gene Therapy Would Make Cells Invulnerable to HIV - Conference Coverage (SPIRAT/NCDDG-HIV)
Gallo Team Isolates Anti-HIV Factors From Pregnancy Hormone - Conference Coverage (SPIRAT/NCDDG-HIV)
T-Cell Homeostasis Seen As Key to Immune Regeneration - Coagulation
Bacterial Blood-Clotting Enzyme Discovered; Linked to Gum & Heart Disease - Funding
Bank Approves US$87.4 Million for Communicable Disease Control In Indonesia - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
